Where is Abbott Laboratories's net income disclosed?
The figure, the filing and period it comes from, and the reported definition.
The answer
$6.52B
Net income, fiscal year ending Dec 31, 2025
Document: 10-K filed 2026-02-20 (accession 0001628280-26-010185)
Reported as XBRL element NetIncomeLoss (Net Income (Loss) Attributable to Parent).
Definition: The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Calculation: none — the value is reported directly.
Source register
| Period end | Value | Form | Filed | Accession |
|---|---|---|---|---|
| Dec 31, 2018 | $2.37B | 10-K | 2021-02-19 | 0001104659-21-025751 |
| Dec 31, 2019 | $3.69B | 10-K | 2022-02-18 | 0001104659-22-025141 |
| Dec 31, 2020 | $4.50B | 10-K | 2023-02-17 | 0001628280-23-004026 |
| Dec 31, 2021 | $7.07B | 10-K | 2024-02-16 | 0001628280-24-005348 |
| Dec 31, 2022 | $6.93B | 10-K | 2025-02-21 | 0001628280-25-007110 |
| Dec 31, 2023 | $5.72B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2024 | $13.40B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2025 | $6.52B | 10-K | 2026-02-20 | 0001628280-26-010185 |